Read about recent events, essential information and the latest community news.
Janet MacPherson, PhD Senior Editor, ISCT Telegraft NSW Health Pathology SLHD Cell Therapy Program Australia Last month I had the privilege to connect and chat with one of the early leaders of Read more...
Patrick Foong, PhD ISCT Ethics of Cell and Gene Therapy (ECGT) Committee Western Sydney University Australia Reviewed by the ISCT ECGT Committee. The US Supreme Court (SCOTUS) has decided not Read more...
Kara Wacker, MBA, RAC ISCT North America LRA Committee Foundation or the Accreditation of Cellular Therapy United States Tuula Rintala European Society for Blood and Marrow Transplantation (EBMT) Read more...
Left to right: Laura Barrachina, Pierre Springuel, Elani Wiest, Thomas Spoerer, Raniero Chimienti, Nikita Patel, Manuela Romano, Gemma Moir-Meyer, Tamas Laufer and Ashley Geiger. Gemma Moir-Meyer, Read more...
Adaeze Ekwe, MSc, PhD Junior Associate Editor, ISCT Telegraft Queensland University of Technology Australia Are you an ISCT member eager to expand your professional network, sharpen your scientific Read more...
Ashley Krull, Ph.D. Contributing Editor, ISCT Telegraft Associate Director, Cell Therapy Manufacturing and Engineering James Cancer Hospital Cellular Therapy Laboratory Assistant Professor, Hematology Read more...
C. Russell Y. Cruz, MD, PhD Senior Editor, ISCT Telegraft Associate Professor, Children's National Hospital United States “If I seem to see further,” Isaac Newton once famously said, “it is by standing Read more...
Tracy TreDenick, BA BTL Co-Founder, Head of Regulatory & Quality BioTech Logic Dark Horse Consulting Group Early-stage biopharma companies often face the same challenge: the need for quality oversight Read more...
Joanna Niska-Blakie, PhD Global Product Manager Qiagen Poland Introduction Manufacturing therapeutics, especially viral vectors for cell and gene therapy, demands rigorous safety standards Read more...
Gene therapy is reshaping how we approach genetic disorders, turning what was once considered untreatable into areas of possibility. With over 30 FDA-approved treatments and more than 2,000 therapies currently Read more...